Xponance, Inc. Dr Reddys Laboratories LTD Transaction History
Xponance, Inc.
- $12.3 Billion
- Q3 2025
A detailed history of Xponance, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Xponance, Inc. holds 13,223 shares of RDY stock, worth $184,328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,223
Previous 15,913
16.9%
Holding current value
$184,328
Previous $239,000
23.01%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RDY
# of Institutions
250Shares Held
94.4MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$182 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A610.2MShares$142 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.78MShares$122 Million0.17% of portfolio
-
Aikya Investment Management LTD London, X06.72MShares$93.6 Million26.28% of portfolio
-
Morgan Stanley New York, NY6.32MShares$88.1 Million0.01% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.31B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...